AzTrials
AzTrials

Fixation of Double Barrel Vascularized FibulaNCT04704167

3D Titanium Miniplates Versus 3D Titanium Mesh Method of Fixation for Double Barrel Vascularized Fibular Graft

A study testing fixation of double barrel vascularised fibula in people with Fixation of Double Barrel Vascularized Fibula, run by Cairo University at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The double barrel fibula flap presents many advantages such as adequate, constant geometry, proper dimensions for implant placement, double periosteal and medullary blood supply allowing multiple osteotomies, correct contouring, an adequate pedicle length and low donor site morbidity. Read more about this study

Who is it for?
Any age
What is being tested?
fixation of double barrel vascularised fibula
Could I receive a placebo?
No, everyone receives an active treatment
How many people
20 participants
Where
1 siteEgypt
Study dates
19 Dec 2020to 17 Jan 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • Patient who require mandibular resection due to tumor, trauma, osteomyelitis or osteoradionecrosis.
  • Patient with Mandibular defect >6 centimeter (cm).

Who cannot join

  • • Patients with systemic condition counteracting with the surgical procedure.
  • Patients with conditions contraindicating fibular flap.

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Cairo University

    Giza, Cairo Governorate, 12613

Other trials in Egypt

About this study

Official title: Comparison of 3D Titanium Miniplates Versus 3D Titanium Mesh Tray as a Method of Fixation for Double Barrel Vascularized Fibular Graft for Mandibular Reconstruction: Randomized Clinical Trial.

The double barrel fibula flap presents many advantages such as adequate, constant geometry, proper dimensions for implant placement, double periosteal and medullary blood supply allowing multiple osteotomies, correct contouring, an adequate pedicle length and low donor site morbidity. Bone thickness, height and its bi-cortical structure seem to be ideal for long-term implant prosthetic rehabilitation. Fixation of double barrel fibula could be done using 3D titanium mini-plate which offers a low profile, less hardware and less chance to remove for later implant placement. Aim of the study is to compare the efficiency of fixation double barrel vascularized fibular graft for mandibular reconstruction using 3D miniplate versus 3D titanium mesh tray

Read the detailed description

Aim of the study is to compare the efficiency of fixation double barrel vascularized fibular graft for mandibular reconstruction using 3D miniplate versus 3D titanium mesh tray

Hypothesis:

Null hypothesis: There is no difference in the clinical and radio graphical parameters between 3D miniplate fixation versus a 3D titanium mesh tray fixation of double barrel vascularized fibular graft.

If the results are significant (i.e. results are unlikely to be explained by chance alone), the null hypothesis is rejected.

Primary objective: to evaluate bone height changes for double barrel vascularized fibular graft after mandibular reconstruction.

Secondary objective: to evaluate volumetric bone changes for double barrel vascularized fibular graft after mandibular reconstruction.

monitoring success of double vascularized fibular graft in mandibular reconstruction.

Trial design:

  • Randomized clinical trial
  • A trial will be carried out by a research in Oral \&Maxillofacial Surgery department and Ahmed Maher Hospital
  • Equal randomization: participants with equal probabilities for intervention and allocation and ratio 1:1.
  • Positive controlled: Both groups receiving treatment.
  • Parallel group study: Each group of patients receives a single treatment simultaneously.

Preoperative phase:

Patients will be subjected to:

  • Case history including personal data, medical, surgical and family history.
  • Clinical examination.
  • Multi-Slice Computed tomography (CT) for mandible.
  • Measuring the defect size
  • Computed angiography for the lower limbs.
  • Preoperative anaesthesia assessment for fitness for general anaesthesia.
  • A Foot Allen Test9
  • A stereolithographic model for the patient mandible with reconstructed with double barrel vascularized fibular graft will be printed.

Operative Phase:

  • Scrubbing and draping of the patient will be carried out in a standard fashion using betadine surgical scrub.
  • Apron incision in neck is done in usual manner
  • Exposure of neck vessel (external carotid artery and external jugalr vein and their branches)
  • Harvesting fibula in usual manner.
  • Splitting the fibula to increase its vertical height using double barrel technique and follow planned mandibular contour.
  • Fixing the harvest fibula flap to the remaining mandible with reconstruction plate.
  • Fixing the top part of the harvested fibula with 3D titanium miniplate or 3D titanium mesh tray (0.6 mm thickness).
  • Anastomosing the peroneal artery and vein with the corresponding neck artery and vein
  • The remaining flexor halluces longus muscle is sutured to the tibialis posterior muscle and to the interosseous membrane to help preserve great toe flexion.
  • A suction drain may be placed between the muscles exiting the inferior limit of the skin incision.
  • Closure of skin incision of neck and lower limb in usual manner and placement of drains.

Post-operative phase:

Post-operative medication:

  • Amoxicillin/Clavulanic acid 1.5 gram vial injection every 12 hour for 5 days
  • Diclofenac Potassium 75mg ampoule Intramuscular injection every 12 hour for 5 days
  • Corticosteroids injection for the first 2 days.
  • Anticoagulant Subcutaneous injection for 5 days

Post-operative wound care:

  • Evaluate suction drains daily and remove them only when <30 mL of serum is collected within a 24 h period.
  • Adequate compression is provided by circumferentially wrapping the leg with a compressive, but not too tight, dressing.

No ambulation is allowed within the first 2 weeks. Upon ambulation, partial weightbearing is begun with the aid of crutches followed by full weight bearing ambulation

. Recruitment:

  • Patients will be selected by the supervisors and the researcher from outpatient clinic of Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, Cairo University- and Ahmed Maher Hospital.
  • Screening of patients will continue until the target population is achieved.
  • Identifying and recruiting potential subjects is achieved through patient database.
  1. Assignment of interventions

Allocation:

Randomization:

The total sample size n= will be calculated and the sample sizes in each group will be pre-specified exactly and are under the direct control of the investigator.

  1. Method of random sequence generation: (computerized random number generator).
  2. Allocation ratio: (1:1).
  3. Type of randomization: simple

Allocation concealment mechanism:

cards will take the generated sequence numbers one number for each card then these cards will be placed within opaque sealed envelopes. Then these Envelops will be placed in a container (box), each participant will grasp one envelop blindly during the preoperative preparation.

Implementation Senior supervisor (EH) is the person who will generate the allocation sequence. Principal investigator (HO) will enroll the participants and assign the participants for intervention.

Masking/blinding:

Because the two interventions used in this trial are easily recognized by the participants and the investigator, neither the investigator (HO) nor the participant can be blinded. But the statistician will be blinded.

  1. Data collection, management, and analysis:

Data collection methods (HO) who will be responsible for outcomes assessment. Information on demographic data and past and concurrent medical history was obtained by interviewing the patient.

During Visit 1 (T1 Surgery day), Data regarding personal information, operative procedure (including surgical procedure- intraoperative complications- operation time) and postoperative complication will be recorded each in the specified section in prepared form. At (T2 one week postoperatively) follow-up scheduled for stitch removal and any complications also will be recorded. In the visit 3\&4 (T3 \& T4 at 3\& 6months) patient will be recalled for routine follow-up.

Being tested
fixation of double barrel vascularised fibula
Keywords
mandibular reconstruction, double barrel vascularized fibula, 3d plate, 3d titanium mesh

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • fixation of double barrel vascularised fibulaOther

    3D titanium miniplate or 3D titanium mesh tray are used as a method of fixation for double barrel vascularized fibula

Study groups in NCT04704167
Study groupRoleWhat they receive
3D titanium mesh trayActive comparator3D titanium mesh tray as a method of fixation for double-barrel vascularized fibula
Receives: Other: fixation of double barrel vascularised fibula
3D titanium miniplateExperimental3D titanium miniplate as a method of fixation for double-barrel vascularized fibula
Receives: Other: fixation of double barrel vascularised fibula

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. bone height changes for the double barrel vascularized fibular graft

    measure bone height changes for the double barrel vascularized fibular graft

    Measured: 6 months

Secondary outcomes (2)
  1. volumetric bone changes for the double barrel vascularized fibular graft

    measure volumetric bone changes for the double barrel vascularized fibular graft

    Measured: 6 months

  2. monitoring viability of the double barrel free vascularized graft

    monitoring viability of the double barrel free vascularized graft

    Measured: 2 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Jan 2021
  2. Study start19 Dec 2020
  3. Primary completion19 Dec 2023
  4. Study completion17 Jan 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
20 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04704167
Sponsor's protocol ID
OMFS3-3-17
Status last verified
Mar 2024
First submitted
8 Jan 2021
Last updated
13 Mar 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided: All collected IPD will be shared

Questions about this trial

What is this clinical trial studying?

A study testing fixation of double barrel vascularised fibula in people with Fixation of Double Barrel Vascularized Fibula, run by Cairo University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 13 Mar 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

bone height changes for the double barrel vascularized fibular graft (time frame: 6 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Mar 2024.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in